Updated Jul 16, 2026
Pangalos Menelas N has filed 3 SEC Form 4 filings across 2 companies in the last 90 days — buying. Lifetime open-market purchases: $661K.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-11 | BIIB | BIOGEN INC. | A — Grant or award | 1.5K | $0.00 | |
| 2026-06-11 | BIIB | BIOGEN INC. | M — Option exercise | 2.4K | $0.00 | |
| 2026-06-09 | ABSI | Absci Corp | A — Grant or award | 10.1K | $0.00 | |
| 2026-05-13 | ABSI | Absci Corp | P — Open-market purchase | 37.5K | $5.36 | $201K |
| 2026-03-05 | ABSI | Absci Corp | A — Grant or award | 5.8K | $0.00 | |
| 2026-03-03 | ABSI | Absci Corp | P — Open-market purchase | 75.1K | $2.74 | $206K |
| 2025-09-22 | ABSI | Absci Corp | P — Open-market purchase | 95.8K | $2.66 | $255K |
Pangalos Menelas N is a corporate insider — currently tracked as Director of BIOGEN INC. (BIIB). InsiderAlpha tracks every SEC Form 4 filing in real time.
3 primary Form 4 filings in the last 90 days, covering 2 companies.
Recorded transactions: 3 open-market purchases ($661K) and 0 open-market sales () across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Pangalos Menelas N profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.